LINC02393
gene geneOn this page
Also known as FLJ37505
Summary
LINC02393 (long intergenic non-protein coding RNA 2393, HGNC:53320) is a long non-coding RNA gene on chromosome 12q24.32.
At a glance
- Gene type: non-coding (lncRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:53320 |
| Approved symbol | LINC02393 |
| Name | long intergenic non-protein coding RNA 2393 |
| Location | 12q24.32 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Aliases | FLJ37505 |
| Ensembl gene | ENSG00000256597 |
| Ensembl biotype | lncRNA |
| Entrez | 400087 |
| RNAcentral | URS000075D06B — lncRNA, 2020 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 3 lncRNA
ENST00000536342, ENST00000614177, ENST00000662498
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000536342 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002220092 | 127882556 | 127882707 |
| ENSE00002278924 | 127881617 | 127881731 |
| ENSE00002312313 | 127882853 | 127882991 |
Expression profiles
Bgee: expression breadth broad, 85 present calls, max score 91.60.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0343 / max 7.1836, expressed in 15 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 206954 | 0.0343 | 15 |
Top tissues by expression
85 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 91.60 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 75.87 | gold quality |
| placenta | UBERON:0001987 | 68.80 | gold quality |
| lymph node | UBERON:0000029 | 62.97 | gold quality |
| monocyte | CL:0000576 | 61.20 | gold quality |
| gall bladder | UBERON:0002110 | 60.17 | gold quality |
| adrenal tissue | UBERON:0018303 | 58.52 | gold quality |
| ventricular zone | UBERON:0003053 | 58.14 | silver quality |
| islet of Langerhans | UBERON:0000006 | 56.88 | gold quality |
| prefrontal cortex | UBERON:0000451 | 56.51 | gold quality |
| ganglionic eminence | UBERON:0004023 | 56.47 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 55.98 | gold quality |
| primary visual cortex | UBERON:0002436 | 55.73 | gold quality |
| muscle of leg | UBERON:0001383 | 54.98 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 54.06 | gold quality |
| endometrium | UBERON:0001295 | 53.17 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 53.15 | gold quality |
| right adrenal gland | UBERON:0001233 | 52.66 | gold quality |
| frontal cortex | UBERON:0001870 | 52.53 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 51.74 | gold quality |
| ascending aorta | UBERON:0001496 | 51.40 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 51.20 | gold quality |
| blood | UBERON:0000178 | 51.11 | silver quality |
| adrenal gland | UBERON:0002369 | 50.67 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 50.48 | gold quality |
| cerebral cortex | UBERON:0000956 | 49.84 | gold quality |
| right frontal lobe | UBERON:0002810 | 49.67 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 49.62 | gold quality |
| cerebellum | UBERON:0002037 | 49.45 | gold quality |
| cerebellar cortex | UBERON:0002129 | 48.73 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.95 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.